Cargando…

Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host

Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominan...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra-Dewasthaly, Rohini, Spergser, Joachim, Zimmermann, Martina, Citti, Christine, Jechlinger, Wolfgang, Rosengarten, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634654/
https://www.ncbi.nlm.nih.gov/pubmed/28957426
http://dx.doi.org/10.1371/journal.ppat.1006656
_version_ 1783270135966990336
author Chopra-Dewasthaly, Rohini
Spergser, Joachim
Zimmermann, Martina
Citti, Christine
Jechlinger, Wolfgang
Rosengarten, Renate
author_facet Chopra-Dewasthaly, Rohini
Spergser, Joachim
Zimmermann, Martina
Citti, Christine
Jechlinger, Wolfgang
Rosengarten, Renate
author_sort Chopra-Dewasthaly, Rohini
collection PubMed
description Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominant Vpma lipoproteins via Xer1-mediated site-specific recombinations. Phase-Locked Mutants (PLMs) expressing single stable Vpma products served as first breakthrough tools in mycoplasmology to study the role of such sophisticated antigenic variation systems. Comparing the general clinical features of sheep infected with a mixture of phase-invariable PLMs (PLMU and PLMY) and the wild type strain, it was earlier concluded that Vpma phase variation is not necessary for infection. Conversely, the current study demonstrates the in vivo indispensability of Vpma switching as inferred from the Vpma phenotypic and genotypic analyses of reisolates obtained during sheep infection and necropsy. PLMY and PLMU stably expressing VpmaY and VpmaU, respectively, for numerous in vitro generations, switched to new Vpma phenotypes inside the sheep. Molecular genetic analysis of selected ‘switchover’ clones confirmed xer1 disruption and revealed complex new rearrangements like chimeras, deletions and duplications in the vpma loci that were previously unknown in type strain PG2. Another novel finding is the differential infection potential of Vpma variants, as local infection sites demonstrated an almost complete dominance of PLMY over PLMU especially during early stages of both conjunctival and intramammary co-challenge infections, indicating a comparatively better in vivo fitness of VpmaY expressors. The data suggest that Vpma antigenic variation is imperative for survival and persistence inside the immunocompetent host, and although Xer1 is necessary for causing Vpma variation in vitro, it is not a virulence factor because alternative Xer1-independent mechanisms operate in vivo, likely under the selection pressure of the host-induced immune response. This singular study highlights exciting new aspects of mycoplasma antigenic variation systems, including the regulation of expression by host factors.
format Online
Article
Text
id pubmed-5634654
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56346542017-10-30 Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host Chopra-Dewasthaly, Rohini Spergser, Joachim Zimmermann, Martina Citti, Christine Jechlinger, Wolfgang Rosengarten, Renate PLoS Pathog Research Article Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominant Vpma lipoproteins via Xer1-mediated site-specific recombinations. Phase-Locked Mutants (PLMs) expressing single stable Vpma products served as first breakthrough tools in mycoplasmology to study the role of such sophisticated antigenic variation systems. Comparing the general clinical features of sheep infected with a mixture of phase-invariable PLMs (PLMU and PLMY) and the wild type strain, it was earlier concluded that Vpma phase variation is not necessary for infection. Conversely, the current study demonstrates the in vivo indispensability of Vpma switching as inferred from the Vpma phenotypic and genotypic analyses of reisolates obtained during sheep infection and necropsy. PLMY and PLMU stably expressing VpmaY and VpmaU, respectively, for numerous in vitro generations, switched to new Vpma phenotypes inside the sheep. Molecular genetic analysis of selected ‘switchover’ clones confirmed xer1 disruption and revealed complex new rearrangements like chimeras, deletions and duplications in the vpma loci that were previously unknown in type strain PG2. Another novel finding is the differential infection potential of Vpma variants, as local infection sites demonstrated an almost complete dominance of PLMY over PLMU especially during early stages of both conjunctival and intramammary co-challenge infections, indicating a comparatively better in vivo fitness of VpmaY expressors. The data suggest that Vpma antigenic variation is imperative for survival and persistence inside the immunocompetent host, and although Xer1 is necessary for causing Vpma variation in vitro, it is not a virulence factor because alternative Xer1-independent mechanisms operate in vivo, likely under the selection pressure of the host-induced immune response. This singular study highlights exciting new aspects of mycoplasma antigenic variation systems, including the regulation of expression by host factors. Public Library of Science 2017-09-28 /pmc/articles/PMC5634654/ /pubmed/28957426 http://dx.doi.org/10.1371/journal.ppat.1006656 Text en © 2017 Chopra-Dewasthaly et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chopra-Dewasthaly, Rohini
Spergser, Joachim
Zimmermann, Martina
Citti, Christine
Jechlinger, Wolfgang
Rosengarten, Renate
Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title_full Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title_fullStr Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title_full_unstemmed Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title_short Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
title_sort vpma phase variation is important for survival and persistence of mycoplasma agalactiae in the immunocompetent host
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634654/
https://www.ncbi.nlm.nih.gov/pubmed/28957426
http://dx.doi.org/10.1371/journal.ppat.1006656
work_keys_str_mv AT chopradewasthalyrohini vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost
AT spergserjoachim vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost
AT zimmermannmartina vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost
AT cittichristine vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost
AT jechlingerwolfgang vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost
AT rosengartenrenate vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost